Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and Epstein-Barr Virus Infections

pyrrolidine dithiocarbamate has been researched along with Epstein-Barr Virus Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bird, PI; Classen, CF; Debatin, KM1

Other Studies

1 other study(ies) available for pyrrolidine dithiocarbamate and Epstein-Barr Virus Infections

ArticleYear
Modulation of the granzyme B inhibitor proteinase inhibitor 9 (PI-9) by activation of lymphocytes and monocytes in vitro and by Epstein-Barr virus and bacterial infection.
    Clinical and experimental immunology, 2006, Volume: 143, Issue:3

    Topics: Acute Disease; Adult; Bacterial Infections; Cells, Cultured; Child; Dexamethasone; Epstein-Barr Virus Infections; Flow Cytometry; Glucocorticoids; Granulocytes; Granzymes; Humans; Interleukin-2; Lipopolysaccharides; Lymphocyte Activation; Lymphocyte Subsets; Monocytes; NF-kappa B; Pyrrolidines; Serine Endopeptidases; Serine Proteinase Inhibitors; Serpins; Thiocarbamates; Up-Regulation

2006